Ej. Steenbergen et al., CLONAL EVOLUTION OF IMMUNOGLOBULIN HEAVY-CHAIN REARRANGEMENTS IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER ENGRAFTMENT IN SCID MICE, Leukemia, 10(9), 1996, pp. 1471-1478
We grafted childhood B-precursor acute lymphoblastic leukemia (ALL) bo
ne marrow (BM) cells into mice with severe combined immunodeficiency (
SCID), in order to study the clonal evolution of immunoglobulin heavy
chain (IgH) rearrangements in the absence of selective pressure by che
motherapy, BM cells from nine patients (six diagnosis samples and thre
e relapse samples) were intravenously injected into SCID mice (three m
ice for each patient). All mice injected with cells from four patients
developed a leukemia-like illness 12-40 weeks after injection. By PCR
, new subclones that were the result of ongoing IgH rearrangement acco
rding to the mechanism operative in the injected cell populations (V-H
-replacement or V-H to D-J(H) joining) were detected in the engrafted
cell populations for all four patients. Subclones were mouse-specific,
suggesting that subclone formation is a continuous process. Southern
analysis after engraftment was unaltered as compared to the injected c
ells for one patient and revealed changes indicative of altered clonal
composition for three patients. For two patients the observed changes
possibly reflect the initial engraftment of a limited number of cells
and occurred without changes in other parameters of the engrafted cel
l population, such as time needed for the development of leukemia, mac
roscopic organ involvement, immunophenotype and S-phase fraction. In o
ne patient, we demonstrated the selective outgrowth of only a single c
ell type present at diagnosis, as characterized by IgH rearrangements.
Our data show that evolution of clonal IgH rearrangements in B-precur
sor ALL may occur without the selective pressure of chemotherapy. Addi
tionally, in some patients subclones present at diagnosis, as defined
by IgH rearrangements, also possess different biological properties.